Eyconis INC.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration (NCT07587515) | Eyconis INC. | 2026-05-19 |
Track Eyconis INC. automatically
Every clearance here is in the API, with alerts when new ones post.